PERRIGO Co plc
PRGO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585364
No open-market purchases or sales by PERRIGO Co plc insiders were filed in the last 90 days; 342 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Maverick Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:18 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $1.43B (33.5% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 27, 2024 | Feb 27, 2023 | Mar 1, 2022 |
| Revenue | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B |
| Cost of revenue | $2.76B | $2.83B | $2.98B | $3.00B | $2.72B |
| Gross profit | $1.49B | $1.54B | $1.68B | $1.46B | $1.42B |
| Operating expenses | $2.62B | $1.43B | $1.53B | $1.38B | $1.01B |
| Research and development | $95.4M | $112.2M | $122.5M | $123.1M | $122.0M |
| Selling, general and administrative | $435.9M | $468.0M | $522.3M | $512.3M | $482.0M |
| Operating income | -$1.12B | $112.9M | $151.9M | $78.9M | $410.4M |
| Income tax | $104.4M | $80.0M | -$3.90M | -$8.20M | $389.6M |
| Net income | -$1.43B | -$171.8M | -$12.7M | -$140.6M | -$68.9M |
| EPS, basic | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
| EPS, diluted | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
| Weighted shares, basic | 138.5M | 137.4M | 135.3M | 134.5M | 133.6M |
| Weighted shares, diluted | 138.5M | 137.4M | 135.3M | 134.5M | 133.6M |
| Margins and growth | |||||
| Gross margin | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% |
| Operating margin | -26.4% | 2.6% | 3.3% | 1.8% | 9.9% |
| Net margin | -33.5% | -3.9% | -0.3% | -3.2% | -1.7% |
| Revenue growth, year over year | −2.8% | −6.1% | +4.6% | +7.6% | −18.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 27, 2024 | Feb 27, 2023 | Mar 1, 2022 |
| Cash and equivalents | – | – | – | $600.7M | $1.86B |
| Accounts receivable | $612.8M | $642.3M | $739.6M | $697.1M | $652.9M |
| Inventory | $1.15B | $1.08B | $1.14B | $1.15B | $1.02B |
| Total current assets | $2.80B | $2.48B | $2.83B | $2.72B | $3.86B |
| Property, plant and equipment | $898.7M | $917.8M | $916.4M | $926.3M | $864.1M |
| Goodwill | $2.05B | $3.32B | $3.53B | $3.49B | $3.00B |
| Intangible assets | $4.76B | $4.50B | $5.00B | $5.01B | $3.68B |
| Total assets | $8.54B | $9.65B | $10.8B | $11.0B | $10.4B |
| Accounts payable | $474.5M | $495.2M | $477.7M | $537.3M | $411.2M |
| Short-term debt | $36.6M | $36.4M | $440.6M | $36.2M | $603.8M |
| Total current liabilities | $1.01B | $1.04B | $1.59B | $1.11B | $1.59B |
| Long-term debt | $3.60B | $3.58B | $3.63B | $4.07B | $2.92B |
| Total liabilities | $5.60B | $5.33B | $6.04B | $6.18B | $5.27B |
| Shareholders' equity | $2.94B | $4.32B | $4.77B | $4.84B | $5.15B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 27, 2024 | Feb 27, 2023 | Mar 1, 2022 |
| Operating cash flow | $238.5M | $362.9M | $405.5M | $307.3M | $156.3M |
| Capital expenditures | $93.4M | $118.3M | $101.7M | $96.4M | $152.1M |
| Free cash flow | $145.1M | $244.6M | $303.8M | $210.9M | $4.20M |
| Depreciation and amortization | $337.5M | $325.9M | $359.5M | $338.6M | $312.2M |
| Stock-based compensation | $54.6M | $64.4M | $68.8M | $54.9M | $60.1M |
| Dividends paid | $159.3M | $152.5M | $149.7M | $142.4M | $129.6M |
| Share buybacks | – | – | – | $0 | $0 |
| Investing cash flow | -$75.4M | $78.8M | -$77.5M | -$1.96B | $1.28B |
| Financing cash flow | -$220.5M | -$611.0M | -$187.2M | $421.6M | -$178.7M |
| Net change in cash | -$24.9M | -$192.5M | $150.6M | -$1.28B | $1.24B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.3% | 1.5% | 1.5% | 1.2% | 1.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 138.8M | +0.9% | SEC |
| Jul 31, 2026 | 138.8M | +0.9% | SEC |
| May 1, 2026 | 138.4M | +0.6% | SEC |
| Feb 24, 2026 | 137.6M | +0.9% | SEC |
| Oct 31, 2025 | 137.6M | +0.9% | SEC |
| Aug 1, 2025 | 137.6M | +0.9% | SEC |
| May 2, 2025 | 137.5M | +0.8% | SEC |
| Feb 21, 2025 | 136.5M | +0.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.